Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 78
- 试验地点
- 1
- 主要终点
- Margin
研究概览
简要总结
- Imaging findings (including CT and MRI images) of both well-differentiated G3 PNET and poorly differentiated PNET were studied;
- The CT imaging findings of G3 stage PNET and pancreatic cancer were compared to establish a Logistic regression diagnostic model, and the survival analysis of the two was compared.
- Cox regression was used to study the risk factors for survival prognosis of well-differentiated and poorly differentiated PNET based on CT image features
详细描述
According to the latest WHO Classification of Neuroendocrine Neoplasms (NET) in 2019, pancreatic neuroendocrine neoplasms (PNET) are divided into well-differentiated and poorly differentiated PNETs.The former is divided into G1, G2, and well differentiated G3.There are few studies on the survival outcomes of these two differentiated PNET types.The G3 imaging manifestations of the two types of differentiation have not been studied yet, and G3 PNET is often clinically misdiagnosed as pancreatic cancer, so it is necessary to differentiate the imaging manifestations and survival time of the two types.
A total of 71 patients with PNET in our hospital from January 2012 to January 2019 and 58 patients with pancreatic cancer from February 2014 to August 2015 were retrospectively collected. Complete survival time data of all patients after telephone follow-up were obtained.Since G3 PNET is very rare, the investigators enrolled 9 patients with G3 PNET in the First Affiliated Hospital of Zhejiang University School of Medicine and 7 patients with G3 PNET in the Affiliated Hospital of Air Force Military Medical University from January 2013 to October 2018.
CT images of PNET and pancreatic cancer were analyzed independently by two radiologists specializing in abdominal diagnosis, in which G3 lesions were evaluated simultaneously on MRI images and the others were evaluated only on CT images.Records clinical data and imaging characteristics: gender, age, tumor markers, tumor shape, size, tumor characteristics, edge, the expansion of the shrinking, pancreas, pancreatic pancreatitis, enhancement scan, arterial phase and portal phase lesions and the ratio of pancreatic parenchyma around, liver metastasis, peripheral vascular invasion, lymph node metastasis.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis by pathology and detailed pathological information
- •Enhanced CT examination or biopsy were performed within 2 months before surgery
- •There was no preoperative radiotherapy or chemotherapy
排除标准
- •No Ki-67 index
- •CT value cannot be measured by ROI because of pancreatic atrophy and other reasons
- •No enhanced images or missing images
结局指标
主要结局
Margin
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
well-defined or ill-defined
tumor texture
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
solid;solid and cystic;complex cystic
CT value of pancreas plain scan
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of pancreas plain scan
CT value of pancreas portal phase
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of pancreas portal phase
CT value of lesion artery phase
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of lesion artery phase
CT value of lesion portal phase
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of lesion portal phase
Pancreatic tail contraction
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
Complicated pancreatitis
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
Pancreatic duct/bile duct dilatation
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
CT value of lesion plain scan
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of lesion plain scan
Tumor size
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
Maximum surface size of the lesion (cm)
Tumor location
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
Locations of the pancreas: head, neck, body and tail
Number of lesions
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
Number of lesions
Extrapancreatic tissue invasion
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
Hepatic metastasis
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
Lymphatic metastasis
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
yes or no
CT value of pancreas artery phase
时间窗: preoperative contrast-enhanced CT performed within 2 months before surgery or biopsy
CT value of pancreas artery phase
次要结局
未报告次要终点
